Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.4750 (-1.35%) ($5.4750 - $5.4750) on Tue. Dec. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.28% (three month average) | RSI | 57 | Latest Price | $5.4750(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -3.8% a day on average for past five trading days. | Weekly Trend | CEMI advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) VIXM(43%) VXX(34%) OIH(3%) EWY(-6%) TBT(89%) | Factors Impacting CEMI price | CEMI will decline at least -2.64% in a week (0% probabilities). XHB(-93%) SPY(-72%) XLK(-68%) QQQ(-63%) JNK(-61%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.64% (StdDev 5.28%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $5.86 | 5 Day Moving Average | $5.88(-6.89%) | 10 Day Moving Average | $6.31(-13.23%) | 20 Day Moving Average | $5.86(-6.57%) | To recent high | -27.4% | To recent low | 9.5% | Market Cap | $110m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |